Literature DB >> 18519513

Kinetics of bone marrow blasts during induction and achievement of complete remission in acute myeloid leukemia.

Masamitsu Yanada, Gautam Borthakur, Farhad Ravandi, Carlos Bueso-Ramos, Hagop Kantarjian, Elihu Estey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18519513     DOI： 10.3324/haematol.12825

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  10 in total

1.  Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy.

Authors:  Farhad Ravandi; Jorge Cortes; Stefan Faderl; Susan O'Brien; Guillermo Garcia-Manero; Srdan Verstovsek; Fabio P S Santos; Jianqin Shan; Mark Brandt; Marcos de Lima; Sherry Pierce; Hagop Kantarjian
Journal:  Blood       Date:  2010-10-05       Impact factor: 22.113

2.  Rapid rate of peripheral blood blast clearance accurately predicts complete remission in acute myeloid leukemia.

Authors:  V Vainstein; S A Buckley; O Shukron; E H Estey; J L Abkowitz; B L Wood; R B Walter
Journal:  Leukemia       Date:  2013-11-18       Impact factor: 11.528

Review 3.  Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemia.

Authors:  Mary-Elizabeth Percival; Catherine Lai; Elihu Estey; Christopher S Hourigan
Journal:  Blood Rev       Date:  2017-02-02       Impact factor: 8.250

4.  Value of routine 'day 14' marrow exam in newly diagnosed AML.

Authors:  T Yezefski; H Xie; R Walter; J Pagel; P S Becker; P Hendrie; V Sandhu; K Shannon-Dorcy; J Abkowitz; F R Appelbaum; E Estey
Journal:  Leukemia       Date:  2014-09-10       Impact factor: 11.528

5.  Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group.

Authors:  Sarah Bertoli; Pierre Bories; Marie C Béné; Sylvie Daliphard; Bruno Lioure; Arnaud Pigneux; Norbert Vey; Jacques Delaunay; Vincent Leymarie; Isabelle Luquet; Odile Blanchet; Pascale Cornillet-Lefebvre; Mathilde Hunault; Didier Bouscary; Nathalie Fegueux; Philippe Guardiola; François Dreyfus; Jean Luc Harousseau; Jean Yves Cahn; Norbert Ifrah; Christian Récher
Journal:  Haematologica       Date:  2013-08-23       Impact factor: 9.941

6.  Re-induction therapy in adult patients with acute myeloid leukemia with ≤20 % blasts: A retrospective cohort study.

Authors:  Kavya K Kannan; Paz Vellanki; Scott Isom; Bernard Tawfik; Allison Winter; Heidi D Klepin; Leslie R Ellis; Rupali Roy Bhave; Dianna Howard; Megan Manuel; Sarah Dralle; Susan Lyerly; Bayard L Powell; Timothy S Pardee
Journal:  Leuk Res       Date:  2021-10-21       Impact factor: 3.156

7.  Evaluation of bone marrow aspirates in patients with acute myeloid leukemia at day 14 of induction therapy.

Authors:  João Tadeu D Souto Filho; Monique M Loureiro; Wolmar Pulcheri; José Carlos Morais; Marcio Nucci; Rodrigo D Portugal
Journal:  Diagn Pathol       Date:  2015-07-25       Impact factor: 2.644

8.  Early assessment of response to induction therapy in acute myeloid leukemia using 18F-FLT PET/CT.

Authors:  Eun Ji Han; Bo-Hee Lee; Jeong-A Kim; Young Ha Park; Woo Hee Choi
Journal:  EJNMMI Res       Date:  2017-09-16       Impact factor: 3.138

9.  Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response.

Authors:  Hong Yuen Wong; Anthony D Sung; Katherine E Lindblad; Sheenu Sheela; Gregory W Roloff; David Rizzieri; Meghali Goswami; Matthew P Mulé; Nestor R Ramos; Jingrong Tang; Julie Thompson; Christin B DeStefano; Kristi Romero; Laura W Dillon; Dong-Yun Kim; Catherine Lai; Christopher S Hourigan
Journal:  Front Oncol       Date:  2019-01-15       Impact factor: 6.244

10.  Acute myeloid leukemia: negative prognostic impact of early blast persistence can be in part overcome by a later remission prior to post-induction therapy.

Authors:  Jana Ihlow; Sophia Gross; Leonie Busack; Anne Flörcken; Julia Jesse; Michaela Schwarz; Nina Rosa Neuendorff; Ann-Christin von Brünneck; Ioannis Anagnostopoulos; Seval Türkmen; Igor Wolfgang Blau; Thomas Burmeister; David Horst; Lars Bullinger; Jörg Westermann
Journal:  Haematologica       Date:  2022-08-01       Impact factor: 11.047
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.